(S,R,S)-AHPC-CO-C6-COOH is a high-purity E3 Ligase Ligand-Linker Conjugate specifically designed for use in PROTAC (Proteolysis Targeting Chimera) drug discovery and chemical biology research. This compound features the AHPC (hydroxyproline-derived) core structure that selectively binds to the Von Hippel-Lindau (VHL) E3 ubiquitin ligase, a critical component for targeted protein degradation. The incorporation of a flexible hexanoyl linker (C6) and a terminal carboxylic acid group allows for efficient conjugation with various target ligands, enabling the design and synthesis of custom bifunctional PROTAC molecules. (E3 Ligase Ligand-Linker Conjugates like (S,R,S)-AHPC-CO-C6-COOH are key intermediates in developing next-generation therapeutics. By bringing target proteins into close proximity to the VHL E3 ligase, these molecules harness the cell's ubiquitin-proteasome system to selectively tag and degrade disease-causing proteins. This mechanism offers a powerful alternative to traditional inhibition, potentially addressing previously "undruggable" targets in oncology, neurodegeneration, and immunology. (S,R,S)-AHPC-CO-C6-COOH is ideal for academic and pharmaceutical researchers seeking reliable tools for advancing targeted protein degradation strategies.
Structure of 2172819-75-7
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-CO-C6-COOH is a specialized E3 ligase ligand-linker conjugate developed for advancing the design and synthesis of PROTACs (Proteolysis Targeting Chimeras). This molecule features the (S,R,S)-AHPC ligand, which specifically recruits the von Hippel-Lindau (VHL) E3 ubiquitin ligase complex, attached via a flexible hexyl (C6) linker terminated with a carboxylic acid group for modular conjugation. Its design enables researchers to create highly selective protein degraders for targeted protein knockdown applications.
Mechanism
The mechanism of (S,R,S)-AHPC-CO-C6-COOH centers on its use as an E3 ligase recruiting component in PROTAC construction. The (S,R,S)-AHPC moiety binds selectively to the VHL E3 ligase, while the C6 aliphatic linker provides spatial flexibility and the terminal carboxylic acid allows for further chemical coupling. When incorporated into a PROTAC molecule, it facilitates the recruitment of VHL ligase to a target protein, enabling ubiquitination and subsequent proteasomal degradation of the target, thereby reducing its cellular levels with high specificity.
Applications
(S,R,S)-AHPC-CO-C6-COOH finds broad application in academic and pharmaceutical research focused on targeted protein degradation. It serves as a modular building block for synthesizing VHL-based PROTACs, allowing the exploration of various disease-relevant targets, including oncogenic proteins and epigenetic regulators. Its optimized structure supports the development of next-generation therapeutics and chemical biology tools for validated target identification, mechanism-of-action studies, and drug discovery pipelines aimed at undruggable proteins.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.